Insights : sector - Osborne Clarke

Life Sciences and Healthcare

Industries making an impact on modern society

Life sciences, health and social care are vitally important in the development of modern society, with a complex network of stakeholders, from the general public and clinical practitioners to regulators, insurers and governments. We understand the unique challenges of the industry and deliver results-focused advice for a diverse range of clients, from drug developers to healthcare providers and the entities that finance and support them.

Learn more about this sector

Article list

Regulatory and compliance

Covid-19 and mental health figure large in latest health and safety statistics

The Health and Safety Executive has published its injury and ill-health statistics for 2021: what's changed?

05/01/2022

Regulatory and compliance

Covid-19 and mental health figure large in latest health and safety statistics

05/01/2022

Life Sciences and Healthcare

LSPN Live | Strategies in Second Medical Use Cases

22/12/2021

Life Sciences and Healthcare

Are European advertising laws ready for patient support programmes?

The legal situation in Europe regarding advertisement of PSPs is highly fragmented with different jurisdictions taking varying approaches to address...

06/12/2021

Intellectual property

Trade secrets remain the sticking point in global debate over a vaccine IP waiver

A consensus on the vaccine IP waiver is yet to be reached, but will the cancellation of WTO's 12th Ministerial...

03/12/2021

Intellectual property

Supreme Court gives certainty to patentees in unlawful means economic tort claims

Dealing requirement upheld as an essential component of the tort, leaving intact the current system for litigating patents in the...

09/11/2021

COP26

COP26 | Energy Day

Welcome to the fourth instalment of our daily COP26 updates: a digest of what is on the agenda each day...

04/11/2021

Sustainable disruption: 12 decarbonising technologies for cities

Can sustainable disruption and technology deliver decarbonised cities?

Against the backdrop of COP26, the reduction of carbon emissions in cities and identifying methodology, technology and investment to achieve...

02/11/2021

COP26

COP26 | World Leaders' Summit begins

Welcome to the first instalment of our daily COP26 updates: a digest of what is on the agenda each day...

01/11/2021

Life Sciences and Healthcare

EUIPO trade mark decision makes protection for medical devices harder to achieve

Boehringer's EU shape trade mark for its HandiHaler declared invalid for performing a technical function

26/10/2021

Sustainable disruption: 12 decarbonising technologies for cities

New research by Economist Impact, supported by Osborne Clarke, has identified 12 technologies that can help cities achieve their carbon-emission...

20/10/2021

Read time 2m

Life Sciences and Healthcare

UK sets out plans to diverge from EU regime on gene editing in plants

The government has signalled its intention to pave the way for gene-edited crops following a consultation on departing from EU...

01/10/2021

Read time 4m

Life Sciences and Healthcare

The government has vision for the UK as the world's leading hub for life sciences

Details on the funding of the 10-year strategy, which builds on the UK's world-class capability and on lessons from the...

22/09/2021

Read time 5m

Life Sciences and Healthcare

Dealing with healthcare data: an overview of the key European markets

20/07/2021

Life Sciences and Healthcare in focus

Hemp tea - the fine line between food and narcotics

The first article from our series "Cannabis - the 'green gold' from a legal perspective"

02/07/2021

Life Sciences and Healthcare

Debate intensifies over a vaccine IP waiver's impact on future pharma and biotech discoveries

Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?

17/05/2021

View all insights

Regulatory and compliance

Covid-19 and mental health figure large in latest health and safety statistics

The Health and Safety Executive has published its injury and ill-health statistics for 2021: what's changed?

05/01/2022

Regulatory and compliance

Covid-19 and mental health figure large in latest health and safety statistics

05/01/2022

Life Sciences and Healthcare

LSPN Live | Strategies in Second Medical Use Cases

22/12/2021

Life Sciences and Healthcare

Are European advertising laws ready for patient support programmes?

The legal situation in Europe regarding advertisement of PSPs is highly fragmented with different jurisdictions taking varying approaches to address...

06/12/2021

Intellectual property

Trade secrets remain the sticking point in global debate over a vaccine IP waiver

A consensus on the vaccine IP waiver is yet to be reached, but will the cancellation of WTO's 12th Ministerial...

03/12/2021

Intellectual property

Supreme Court gives certainty to patentees in unlawful means economic tort claims

Dealing requirement upheld as an essential component of the tort, leaving intact the current system for litigating patents in the...

09/11/2021

COP26

COP26 | Energy Day

Welcome to the fourth instalment of our daily COP26 updates: a digest of what is on the agenda each day...

04/11/2021

Sustainable disruption: 12 decarbonising technologies for cities

Can sustainable disruption and technology deliver decarbonised cities?

Against the backdrop of COP26, the reduction of carbon emissions in cities and identifying methodology, technology and investment to achieve...

02/11/2021

COP26

COP26 | World Leaders' Summit begins

Welcome to the first instalment of our daily COP26 updates: a digest of what is on the agenda each day...

01/11/2021

Life Sciences and Healthcare

EUIPO trade mark decision makes protection for medical devices harder to achieve

Boehringer's EU shape trade mark for its HandiHaler declared invalid for performing a technical function

26/10/2021

Sustainable disruption: 12 decarbonising technologies for cities

New research by Economist Impact, supported by Osborne Clarke, has identified 12 technologies that can help cities achieve their carbon-emission...

20/10/2021

Read time 2m

Life Sciences and Healthcare

UK sets out plans to diverge from EU regime on gene editing in plants

The government has signalled its intention to pave the way for gene-edited crops following a consultation on departing from EU...

01/10/2021

Read time 4m

Life Sciences and Healthcare

The government has vision for the UK as the world's leading hub for life sciences

Details on the funding of the 10-year strategy, which builds on the UK's world-class capability and on lessons from the...

22/09/2021

Read time 5m

Life Sciences and Healthcare

Dealing with healthcare data: an overview of the key European markets

20/07/2021

Life Sciences and Healthcare in focus

Hemp tea - the fine line between food and narcotics

The first article from our series "Cannabis - the 'green gold' from a legal perspective"

02/07/2021

Life Sciences and Healthcare

Debate intensifies over a vaccine IP waiver's impact on future pharma and biotech discoveries

Does a proposed patent suspension backed by Washington open a Pandora's box for vaccine R&D and investment?

17/05/2021

View all insights

Silvia Steiner

Partner, International Head of Life Sciences and Healthcare, Spain

+34 93 419 18 18 Email Silvia Full biog

View all

Search results

Insights

Life Sciences and Healthcare

Industries making an impact on modern society

Article list

Connect with one of our experts

Sign up for our newsletter

Legal Notice